Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127420681 | 12742068 | 1 | I | 20160831 | 20160914 | 20160914 | EXP | AR-PFIZER INC-2016414657 | PFIZER | 42.00 | YR | M | Y | 0.00000 | 20160914 | MD | AR | AR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127420681 | 12742068 | 1 | PS | SUNITINIB MALATE. | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (4/2 SCHEME) | 21938 | 50 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127420681 | 12742068 | 1 | Renal cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127420681 | 12742068 | HO |
| 127420681 | 12742068 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127420681 | 12742068 | Disease progression | |
| 127420681 | 12742068 | Hypothyroidism | |
| 127420681 | 12742068 | Lung disorder | |
| 127420681 | 12742068 | Renal cancer metastatic | |
| 127420681 | 12742068 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |